Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immediate Parent -Infant Skin-to-Skin Study (IPISTOSS)

NCT03521310 is registered in ClinicalTrials.gov with Björn Westrup, MD PhD as lead sponsor.

NCT NCT03521310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03521310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immediate Parent -Infant Skin-to-Skin Study (IPISTOSS)
Lead sponsor
Björn Westrup, MD PhD
Phase
Not applicable
Overall status
Terminated
Start date
April 1, 2018
Completion date
October 12, 2021
Enrollment
91 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prematurity